Constantine Davides
Stock Analyst at Citizens
(0.99)
# 3,920
Out of 5,182 analysts
124
Total ratings
29.57%
Success rate
-22.28%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| USPH U.S. Physical Therapy | Maintains: Market Outperform | $113 → $98 | $59.29 | +65.29% | 3 | May 8, 2026 | |
| OMDA Omada Health | Maintains: Market Outperform | $18 → $21 | $14.82 | +41.70% | 2 | May 8, 2026 | |
| ADUS Addus HomeCare | Maintains: Market Outperform | $150 → $142 | $99.57 | +42.61% | 5 | May 6, 2026 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $22 → $24 | $28.97 | -17.16% | 14 | Feb 23, 2026 | |
| PGNY Progyny | Upgrades: Market Outperform | $30 | $23.72 | +26.48% | 4 | Jan 20, 2026 | |
| OPCH Option Care Health | Reiterates: Market Outperform | $36 → $38 | $20.51 | +85.28% | 8 | Jan 13, 2026 | |
| EVH Evolent Health | Maintains: Market Outperform | $11 → $10 | $4.18 | +139.23% | 12 | Jan 6, 2026 | |
| HQY HealthEquity | Maintains: Market Outperform | $117 → $122 | $84.84 | +43.80% | 6 | Dec 4, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $23.06 | +34.43% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $6.44 | +272.67% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Outperform | $48 | $21.38 | +124.51% | 1 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $16.68 | - | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $6.31 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $54.23 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $42.06 | -38.18% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $176.53 | +40.49% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $23.96 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $13.18 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.55 | +238.71% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.85 | +14,689.40% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $26.93 | -44.30% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $22.89 | -1.70% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $2.36 | +260.17% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.67 | +1,989.24% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $0.33 | +109,422.36% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.32 | +246,287.83% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.80 | +4,929.55% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $2.25 | +5,233.33% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.47 | +54,321.77% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $597,600 → $298,800 | $2.26 | +13,221,138.94% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4,400 → $3,400 | $5.12 | +66,306.25% | 2 | Sep 23, 2022 |
U.S. Physical Therapy
May 8, 2026
Maintains: Market Outperform
Price Target: $113 → $98
Current: $59.29
Upside: +65.29%
Omada Health
May 8, 2026
Maintains: Market Outperform
Price Target: $18 → $21
Current: $14.82
Upside: +41.70%
Addus HomeCare
May 6, 2026
Maintains: Market Outperform
Price Target: $150 → $142
Current: $99.57
Upside: +42.61%
AMN Healthcare Services
Feb 23, 2026
Maintains: Market Outperform
Price Target: $22 → $24
Current: $28.97
Upside: -17.16%
Progyny
Jan 20, 2026
Upgrades: Market Outperform
Price Target: $30
Current: $23.72
Upside: +26.48%
Option Care Health
Jan 13, 2026
Reiterates: Market Outperform
Price Target: $36 → $38
Current: $20.51
Upside: +85.28%
Evolent Health
Jan 6, 2026
Maintains: Market Outperform
Price Target: $11 → $10
Current: $4.18
Upside: +139.23%
HealthEquity
Dec 4, 2025
Maintains: Market Outperform
Price Target: $117 → $122
Current: $84.84
Upside: +43.80%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $23.06
Upside: +34.43%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $6.44
Upside: +272.67%
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $21.38
Upside: +124.51%
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $16.68
Upside: -
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $6.31
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $54.23
Upside: -
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $42.06
Upside: -38.18%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $176.53
Upside: +40.49%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $23.96
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $13.18
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.55
Upside: +238.71%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.85
Upside: +14,689.40%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $26.93
Upside: -44.30%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $22.89
Upside: -1.70%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $2.36
Upside: +260.17%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $0.67
Upside: +1,989.24%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $0.33
Upside: +109,422.36%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.32
Upside: +246,287.83%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.80
Upside: +4,929.55%
Mar 16, 2023
Reiterates: Buy
Price Target: $120
Current: $2.25
Upside: +5,233.33%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.47
Upside: +54,321.77%
Sep 28, 2022
Maintains: Buy
Price Target: $597,600 → $298,800
Current: $2.26
Upside: +13,221,138.94%
Sep 23, 2022
Maintains: Buy
Price Target: $4,400 → $3,400
Current: $5.12
Upside: +66,306.25%